Healthcare disparities revealed during the COVID-19 pandemic must be addressed. A simple way to enable care to reach remote or low-resource communities is through inexpensive, rapid, sensitive, and portable biosensors. Here, we discuss work on the development and testing of a lens-free holographic microscopy (LFHM) and agglutination assay-based biosensor capable of rapid and sensitive point-of-care detection of SARS-CoV-2 virus. Additionally, we discuss recent efforts to further improve this sensor by using colloidal gold nanorods and machine learning approaches.
|